Image source: Getty Images
Last week was a reasonably disappointing one for the CSL Limited (ASX: CSL) share price.
Despite releasing its research and development (R&D) update for 2021, the biotherapeutics company’s shares ended the period with a weekly decline of 0.5%.
What was the reaction…
Health9 hours ago
Plant‑Based Diet Makes Man’s Severe Debilitating Migraines Disappear – One Green Planet
Technology24 hours ago
Microsoft Surface Go 3 – a little Windows tablet (mini-review) – CyberShack
General23 hours ago
Big tech, big target, good politics
General21 hours ago
ATAGI to review booster advice ahead of National Cabinet meeting